From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions.
Claire Walker, Timothy Piatkowski, Jason Ferris, Emma Davies, Monica J Barratt, Adam Winstock, Cheneal Puljević
J Psychopharmacol July 29, 2024 DOI: 10.1177/02698811241265762 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 2,552 |
| Population | Respondents to the Global Drug Survey 2020 who reported using psychedelics for self-treatment of mental health conditions |
| Keywords | Mental-health Psychedelics Self-treatment Depression-anxiety Therapeutic-practices |
| Citations | 4 |
| Key findings | Perceived symptom improvement from psychedelic self-treatment was associated with a reduced likelihood of current prescribed medication use for depression or comorbid depression and anxiety. |
Abstract
Introduction: This study explores how individuals self-treat psychiatric conditions with psychedelics outside medical guidance bridging the gap in understanding unregulated therapeutic use.
Aims: The primary objective was to extract specific factors underlying the effects of psychedelics, exploring their relationship with the need for medication, particularly for mental health conditions like depression and anxiety. Additionally, we aimed to understand how the likelihood of being prescribed pharmacological medication varies based on mental health diagnoses and demographic factors.
Methods: This research utilised the Global Drug Survey 2020, an annual online survey focused on substance use patterns and demographics, incorporating modules addressing mental health and psychedelic use. The study employed Exploratory Factor Analysis to discern latent factors underlying the self-reported effects of psychedelics. Bivariable and multivariable logistic regressions were conducted to investigate the association between identified factors and the likelihood of current prescribed medication usage.
Results: In all, 2552 respondents reported using psychedelics for self-treatment of mental health conditions. Three significant factors were identified: Improved Mental Health, Improved Self-Awareness and Neuro-Sensory Changes. The majority of the sample reported a history of depression (80%) or anxiety (65.6%), with a significant association observed between reported factors of psychedelics' effects and current medication usage for mental health, especially notable in cases of depression or comorbid depression and anxiety.
Conclusions: Perceived symptom improvement following psychedelic self-treatment may reduce the need for medically supervised pharmacological interventions. These findings highlight the potential of psychedelics to positively influence mental health and self-awareness, paving the way for further research into their therapeutic application.